Crossmark

Cytokine production by activated plasmacytoid dendritic cells and natural killer cells is suppressed by an IRAK4 inhibitor

Crossref DOI link: https://doi.org/10.1186/s13075-018-1702-0

Published Online: 2018-10-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Hjorton, Karin https://orcid.org/0000-0002-6211-3735
Hagberg, Niklas

Israelsson, Elisabeth

Jinton, Lisa

Berggren, Olof

Sandling, Johanna K.

Thörn, Kristofer

Mo, John

Eloranta, Maija-Leena

Rönnblom, Lars
Funding

Funding for this research was provided by:

Swedish Rheumatism Association, King Gustaf V's 80-years Foundation

Agnes och Mac Rudbergs Stiftelse

AstraZeneca Science for Life Research Collaboration grant

Vetenskapsrådet

Svenska Läkaresällskapet
License Information

Text and Data Mining valid from 2018-10-24
More Information

Article History

Received: 17 April 2018

Accepted: 16 August 2018

First Online: 24 October 2018

Ethics approval and consent to participate

: The local ethics committee of Uppsala approved the study and informed consent was obtained from all participants.

: Not applicable.

: EI, LJ, KT, and JM are employees of AstraZeneca. LR received a research grant from AstraZeneca. The remaining authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.